Fridays Pricing: Understanding Cost and Access Models for GLP-1 Treatment

Last reviewed: May 16, 2026

Last updated: May 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Fridays Pricing refers to a subscription-based delivery model for GLP-1 medications, typically ranging from $99–$299 monthly depending on the compound, concentration, and delivery frequency. Understanding subscription structures helps patients evaluate whether a recurring cost model aligns with their clinical needs and long-term treatment expectations.

GLP-1 pricing varies significantly based on whether the medication is branded (Wegovy, Ozempic) or compounded through licensed pharmacies. PlexusDx prioritizes transparency: we source compounded semaglutide and tirzepatide from 503A pharmacies only, and our Precision Peptide Genetic Test may help contextualize individual factors that influence response patterns and sustainability of any GLP-1 regimen.

How Subscription-Based GLP-1 Pricing Models Differ

Subscription services simplify access by auto-delivering injections or oral medications monthly, removing the need for repeated pharmacy refills. However, subscription models require patient commitment: monthly charges occur regardless of dose changes, missed doses, or temporary discontinuation. This structure suits motivated patients with stable clinical status.

Compounded GLP-1 from 503A pharmacies typically costs $149/mo monthly for semaglutide or tirzepatide, depending on concentration and volume. Branded alternatives (Wegovy, Mounjaro) may range higher, and insurance coverage varies. Subscription models often bundle pharmacy fees, shipping, and provider consultations into one monthly rate, simplifying budgeting.

Cost Factors: What Influences Your Monthly GLP-1 Investment

GLP-1 pricing depends on multiple variables beyond the base medication cost. Dose strength, injection frequency, oral versus injectable form, pharmacy overhead, telemedicine consultation fees, and shipping all contribute. Additionally, individual peptide pathway sensitivity—revealed through genetic testing—may suggest whether higher or lower starting doses are clinically appropriate, affecting both cost and treatment sustainability.

Cost Factor	Impact on Monthly Price
Medication Form	Injectables typically $149/mo; oral formulations $249-$369/mo depending on dose
Dose Strength	Starter doses (lower mcg) often cost less; titration increases costs as tolerance builds
Pharmacy Credentials	Licensed 503A compounding pharmacies ensure consistency; costs reflect rigorous quality oversight
Provider Consultation	Telemedicine check-ins bundled in some plans; separate consultations may add $50–$150/mo
Genetic Context	Precision Peptide Genetic Test ($99–$298) reveals GLP1R and GIPR predispositions to inform dosing decisions

Compounded Versus Branded: Understanding Subscription Price Differences

Branded GLP-1s (Wegovy, Ozempic, Mounjaro) are FDA-approved, mass-produced medications with fixed pricing and insurance pathways. Compounded semaglutide and tirzepatide from 503A pharmacies offer lower entry costs ($149/mo) because they bypass large-scale manufacturing overhead, though they are not FDA-approved drugs and reflect a different regulatory framework.

Neither pricing model guarantees outcomes. Compounded or branded, success depends on adherence, lifestyle integration, and individual metabolic factors. Some patients benefit from genetic insight into GLP1R rs6923761 or GIPR rs1800437 variants before committing to a subscription—this context may help inform whether a slower titration or different starting protocol makes sense clinically.

Who Should Consider a GLP-1 Subscription Model, and Who Should Pause

GLP-1 subscriptions work best for patients with stable insurance coverage, predictable monthly budgets, and clear clinical indication (type 2 diabetes or weight management under provider guidance). Monthly commitment assumes you'll tolerate the medication, maintain consistent dosing, and have access to provider support if side effects or dose adjustments are needed.

Caution is warranted if you're new to GLP-1, pregnant, nursing, or have uncontrolled medical conditions. Starting with a one-time prescription or pay-per-dose model may allow safer titration before enrolling in autopay. A qualified provider—supported by biomarker or genetic context if available—should guide this decision, not pricing alone.

How PlexusDx Supports a More Personalized Approach

PlexusDx Precision Peptide Genetic Testing reveals predispositions in key GLP-1 pathway genes (GLP1R, GIPR, MC4R, FTO variants) that may provide context for how your body engages with GLP-1 medications. This information does not predict exact medication response or guarantee treatment success; rather, it may help support a more personalized conversation with your provider about starting dose, titration pace, and long-term feasibility of a subscription model.

Our Precision Peptide Genetic Test ($99 as an add-on to a treatment plan, or $298 standalone) examines variants like GLP1R rs6923761 and GIPR rs1800437 that research associates with differential GLP-1 sensitivity. Understanding your genetic predispositions may help explain why some patients thrive on microdose protocols ($129/mo) while others benefit from standard concentrations. This context should be interpreted alongside clinical evaluation, not as a replacement for provider assessment.

Combining genetic insight with transparent PlexusDx compounded pricing ($149/mo for semaglutide or tirzepatide) allows you and your provider to make a more informed subscription decision. Rather than committing to a monthly plan based on cost alone, genetic context plus clinical history creates a stronger foundation for sustainable, evidence-informed GLP-1 therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What does Fridays Pricing actually include in its monthly subscription cost?

Fridays-style subscriptions typically bundle the compounded medication, shipping, telemedicine provider access, and pharmacy fees into one monthly rate. Specific inclusions vary by service; confirm whether dose adjustments, follow-up consultations, or genetic testing are separate costs or bundled.

Is compounded GLP-1 cheaper than branded options like Wegovy or Mounjaro?

Compounded semaglutide and tirzepatide from 503A pharmacies typically cost $149/mo, often lower than branded alternatives. However, compounded medications are not FDA-approved and reflect a different regulatory category. Cost alone should not drive the choice; provider guidance on efficacy and safety is essential.

How much does PlexusDx GLP-1 cost monthly, and what's included?

PlexusDx compounded semaglutide ranges $149/mo; tirzepatide $249/mo. Our Microdose GLP-1 Protocol is $129/mo. Pricing reflects licensed 503A pharmacy standards. Consult with a provider to confirm what consultations, testing, and adjustments are included in your plan.

Can genetic testing help me decide if a GLP-1 subscription is right for me?

PlexusDx Precision Peptide Genetic Testing reveals predispositions in GLP1R, GIPR, and metabolic genes that may provide context for GLP-1 response patterns. This should be interpreted with a qualified provider; genetic predisposition does not guarantee treatment success, but may inform starting dose and titration strategy before committing to a ...

What happens if I need to stop my GLP-1 subscription mid-month?

Subscription policies vary by provider. Most allow cancellation with notice, though timing and refund terms differ. PlexusDx and similar services typically offer flexibility, but confirm cancellation and payment terms before enrolling. Discuss pause or dose-reduction options with your provider if side effects occur.